The Psychology Digest

Our current Call for Proposals submission period has ended. Thank you to all that participated. If your proposal has been accepted, you will be notified by February 15, 2026. If you missed the deadline for this session but are still interested in sharing your expertise with Pearson, please reach out to clinicaltraining@pearson.com.

What’s Ahead in season two of the podcast series, “The Progress Profile: Alzheimer’s Research in Focus.”

For most people, video games are a form of entertainment. For Rhoda Au, Ph.D., professor at Boston University, video games represent something far more profound: a potential window into the human brain.

When Dr. Miia Kivipelto launched the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, better known as the FINGER trial, in 2009, the field of dementia prevention was much different.

“At that time, [the focus was only on] high age and genetic factors,” Kivipelto said. “Now we know that 45% of these risk factors are there throughout the whole life course and that’s why we say that it’s never too early to … prevent dementia.”

Kivipelto, a Finnish neuroscientist and professor who specializes in dementia and Alzheimer’s disease, joined John Harrison, Ph.D., CPsychol, CSci, AFBPsS, an associate professor at Alzheimercentrum, AUmc, Amsterdam, for the Pearson-sponsored podcast series, “The Progress Profile: Alzheimer’s Research in Focus,” to share insights into her research.

What decades of research reveal about brain health, early detection, and the future of dementia care

What if one of the most overlooked proteins in the brain turned out to hold the key to understanding—and eventually treating — Alzheimer’s disease?

That question was at the center of a recent Pearson-sponsored podcast series, The Progress Profile: Alzheimer’s Research in Focus. Leading Alzheimer’s researcher Dr. Philip Scheltens joined moderator moderator, John Harrison, Ph.D., CPsychol, CSci, AFBPsS, an associate professor at Alzheimercentrum, AUmc, Amsterdam, to explore how tau has moved from a supporting role in the “amyloid hypothesis” to a central player in diagnosis, imaging, treatment, and precision medicine.

How CAT-MH^® helped one practice save lives

In the world of behavioural health, every moment counts. When someone reaches out for help, there’s often a narrow window of opportunity—one that can close quickly if the right support isn’t available immediately. For Bernie Dyme, a licensed clinical social worker with over four decades of experience, finding ways to maximise that critical window became essential as his practice grew.

What if the young people involved in community violence were just individuals struggling with untreated mental health conditions?

This question lies at the heart of groundbreaking research that’s changing how we understand and address violence in our communities.

Dr Michael Brook, associate professor at Northwestern University’s Feinberg School of Medicine, has spent years studying this connection. His work reveals something most people don’t realise: the majority of young people who become involved in community violence have significant histories of trauma, depression, hopelessness, and other mental health conditions that directly increase their risk.

Dr. Lisa Pellegrin, a licensed clinical psychologist in Tennessee, discovered exactly how to make this happen—and it's changing how she delivers care in her private practice.

What if you could spot undiagnosed ADHD in a 40-year-old father who came in for marriage counseling? Dr. Jared Minkel did exactly that—and it changed his patient's life. But first, the backstory...